To continue using FE Trustnet please choose an edition:

This site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about cookies on the website and how to delete cookies, see our Privacy and Cookie Policy.

I accept the FE Trustnet cookie policy

For more information Click here




It's look like you're leaving us

What would you like us to do with the funds you've selected

Show me all my options Forget them Save them
Customise this table

Following their poor performance this year, are you going to increase your exposure to small cap funds in 2015?



You are here: Factsheet

Contact details

7 Newgate Street, London, EC1A 7NX
0845 766 0184 (Broker Line)
0844 620 0151 (Fax Number)
0845 777 5511 (Main Number)

Fund managers

* Linden Thomson05-Jul-2012 to Present
Gemma Game»01-Mar-2011 to 04-Jul-2012
Deane Donnigan»18-Jun-2010 to 28-Feb-2011
Andy Smith»01-Apr-2008 to 17-Jun-2010
Deane Donnigan»01-Sep-2007 to 31-Mar-2008
Gareth Powell»01-Jan-2004 to 31-Aug-2007
Antony Milford»26-Nov-2001 to 28-Feb-2005

Investment objectives

To provide long-term capital appreciation by investing principally in equity securities of companies in the biotechnology, genomics and medical research industries worldwide.

Key Information

Fund vs sector

  1y 3y
Position 2 / 133 1 / 108
Quartile 1 1

Fund ratings

FE Crown Rating: 5 FE Crown Rating


  1y 3y
Volatility 24.87 19.70
Alpha 44.06 41.39
Beta 0.44 0.86
Sharpe 1.56 2.13
Info Ratio 1.48 2.05
R2 0.01 0.12
Quartiles:   1  2  3  4   help with ratios
vs. Specialist»
performance chart
ACC +50.0+209.0+261.9+52.4+35.2+2.6+14.1
  SPECIALIST   -1.5+10.9+19.7+3.5+8.8-7.4+16.5
Clean share class
   Bid OfferDateYieldOCF help CiticodeSEDOL
pdf AXA FRAMLINGTON BIOTECH Z ACC ACC 268.80 (p) 18-Dec-2014 0.00 0.84% 11VD B784NS1
Other share classes
   Bid OfferDateYieldOCF help CiticodeSEDOL
pdf AXA FRAMLINGTON BIOTECH R INC INC 147.40 (p) 18-Dec-2014 0.00 1.84% FT82 3100714
pdf AXA FRAMLINGTON BIOTECH R ACC ACC 147.10 (p) 18-Dec-2014 0.00 1.84% FR15 3100725

The Ongoing Charges Figure (OCF) shows the drag on performance caused by operational expenses associated with a fund.

Expenses which are represented by this figure include payments to the manager, the trustee the custodian and their representatives. The figure also includes registration, regulatory, audit and legal fees, and the costs of distribution.

Performance fees, transaction costs, interest on borrowing, costs associated with derivatives, entry and exit fees and soft commissions are not included in the OCF calculation, and should be factored in separately by the investor.

The OCF is calculated by taking the sum of these expenses incurred in the last 12 months and dividing this by the average net assets of that class for the last 12 months.

Total Expense Ratio (TER) is a formula designed to show the ongoing costs to the investor associated with a fund, including some charges which are not factored into the annual management fee. In addition the fund’s annual fee, charges such as trading fees, audit and legal fees, and operational expenses are included in the TER, which is worked out by dividing the total cost of the fund by its total assets to arrive at a percentage.

Unlike the Ongoing Charges Figure, the TER takes into account performance fees. It does not include transaction costs paid to the custodian.

Detailed fund information
Fund type flag UK Unit Trust
Own ISA wrapper Fund has ISA Wrapper help with ratios Fund size£502.1m / $785.8m (18-Dec-14)
Savings plan Fund has Savings Plan Minimum: £ 50.0 Monthly Launch26-Nov-2001
Pricing times12:00 Daily Dealing frequencyDaily
Dealing timesMon-Fri 09:00 to 17:30
Minimum initial£ 1,000
Minimum additional£ 100
Initial charge5.50%
Annual management charge1.75%
Note to chargesn/a
Trustee / DepositaryNational Westminster Bank plc
Dividend policyMar 01, Sep 01 (Final)
Peer groups
Region Asset Class Investment Focus Sector
Global Equity Biotech, Health Specialist
Largest holdings, 31-Oct-2014
Holding (%) Rank Fund factsheet Equity factsheet
CELGENE CORP 9.60 1 - -
AMGEN INC 9.30 2 - -
BIOGEN IDEC INC 6.40 4 - -
ILLUMINA INC 4.60 6 - -
INCYTE CORP 3.10 10 - -
Regional weightings, 31-Oct-2014
USA85.581 85.58% USA
Ireland4.662 4.66% Ireland
Money Market3.563 3.56% Money Market
Germany1.074 1.07% Germany
UK1.065 1.06% UK
Switzerland1.036 1.03% Switzerland
Netherlands0.867 0.86% Netherlands
Sweden0.868 0.86% Sweden
France0.699 0.69% France
Spain0.4610 0.46% Spain
Denmark0.1711 0.17% Denmark
Sector weightings, 31-Oct-2014
Biotech Product70.571 70.57% Biotech Product
Specialty Pharma & Pharma15.562 15.56% Specialty Pharma & Pharma
Enabling Technology / Tools5.423 5.42% Enabling Technology / Tools
Cash3.564 3.56% Cash
Drug Delivery2.995 2.99% Drug Delivery
Devices1.436 1.43% Devices
Healthcare Services0.477 0.47% Healthcare Services

All prices in Pence Sterling (GBX) unless otherwise specified. Price total return performance figures are calculated on a bid price to bid price basis (mid to mid for OEICs) with net income (dividends) reinvested. Performance figures are shown in Sterling unless otherwise specified.

Add your comment
Reload Change mode
Enter the words above:
Send comment
Be the first to comment on this Factsheet.

Investment options

pdf View & print PDF Factsheet
mail Email factsheet to a friend
life Click here for AXA Framlington Biotech life wrappers
pension Click here for AXA Framlington Biotech pension wrappers


Latest Fundswire  

Buy this fund here

You can now buy & sell funds and shares at our new sister-site at highly competitive rates

Asset allocation

US Equities, 85.58%
85.5800% ofUS Equities
Irish Equities, 4.66%
4.6600% ofIrish Equities
Money Market, 3.56%
3.5600% ofMoney Market
German Equities, 1.07%
1.0700% ofGerman Equities
UK Equities, 1.06%
1.0600% ofUK Equities
Swiss Equities, 1.03%
1.0300% ofSwiss Equities
Dutch Equities, 0.86%
0.8600% ofDutch Equities
Swedish Equities, 0.86%
0.8600% ofSwedish Equities
French Equities, 0.69%
0.6900% ofFrench Equities
Spanish Equities, 0.46%
0.4600% ofSpanish Equities
Danish Equities, 0.17%
0.1700% ofDanish Equities

FE Adviser Fund Index

Sector analysis


FE Trustnet portfolio

register   login
Register      Login
Use the plus sign add to portfolio on the left to add this fund to your portfolio